SRT3.DE
Sartorius Aktiengesellschaft
XETRAEUREQUITY
Healthcare
DELAYED
Last price
246.80
▼ 2.10 (0.84%)
MARKET · —
Price
Open
248.90
Prev close
248.90
Day high
249.90
Day low
242.20
Volume
60.95K
Market cap
$17.04B
P/E (TTM)
86.29
52W range
187.30 – 267.70
Trailing performance
Returnvs SPY
1W
+3.92%
+5.3%
1M
+11.27%
+7.5%
3M
+5.92%
+2.8%
6M
+8.10%
-3.0%
YTD
-0.16%
-12.5%
1Y
+25.85%
+5.9%
3Y
-31.06%
-105.2%
5Y
-58.32%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$17.04B
Enterprise value$21.98B
Revenue (TTM)$3.58B
Gross profit$1.64B
EBITDA$938.50M
Net income$196.10M
EPS (TTM)$2.86
Free cash flow$324.69M
Total cash$291.30M
Total debt$4.05B
Book value / share$39.20
Shares outstanding34.81M
Float27.45M
Short % of float—
Dividend yield0.30%
Beta (5Y)1.46
Valuation & profitability ratios
Trailing P/E86.29
Forward P/E39.07
PEG ratio0.94
Price / sales—
Price / book6.30
EV / revenue6.14
EV / EBITDA23.42
Gross margin45.71%
Operating margin18.00%
Profit margin5.47%
Return on equity7.18%
Return on assets3.92%
Debt / equity101.37
Current ratio1.14
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $3.54B | $3.38B | $3.40B | $4.17B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $154.90M | $84.00M | $205.20M | $678.10M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $154.90M | $84.00M | $205.20M | $678.10M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.34 | 1.29 | -3.9% |
| Mar 2026 | 1.27 | 1.21 | -4.8% |
| Dec 2025 | 1.32 | 1.26 | -4.5% |
| Sep 2025 | 1.07 | 1.08 | +0.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.22 | 5 | $895.02M | +6.2% |
| Next quarter | 1.52 | 5 | $999.24M | +7.7% |
| Current year | 5.25 | 17 | $3.72B | +5.2% |
| Next year | 6.32 | 17 | $4.08B | +9.7% |
Analyst targets & ownership
Mean target$269.11
High target$307.00
Low target$190.00
Implied upside9.04%
Analyst count19
ConsensusBUY
Strong buy / Buy3 / 11
Hold5
Sell / Strong sell1 / 0
Held by insiders25.61%
Held by institutions30.79%
Institutions holding308
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
17.68M
Total on file
Moving averages & technicals
SMA 10
237.87
+3.75% from price
SMA 20
231.23
+6.73% from price
SMA 50
229.93
+7.34% from price
SMA 100
228.00
+8.25% from price
SMA 200
232.34
+6.23% from price
EMA 12
236.96
+4.15% from price
EMA 26
233.62
+5.64% from price
EMA 50
231.58
+6.57% from price
RSI (14)
61.5
Neutral
MACD (12,26,9)
3.34
Hist 1.66
ATR (14)
7.58
3.07% of price
Realised vol 30D
41.4%
Annualised
Bollinger upper
248.39
20, 2σ
Bollinger lower
214.07
20, 2σ
50 / 200 cross
Death
229.93 vs 232.34
Trend bias
Above 200
+6.23%
Risk profile
Beta vs SPY
0.43
Less volatile than market
Correlation to SPY
0.14
Largely independent
Realised vol 30D
41.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-22.8%
Peak to trough
Max drawdown 5Y
-71.0%
Peak to trough
ATR 14
7.58
3.07% of price
Beta (reported)
1.46
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Ken de la Bastide column: Residents will be dealing with flooding for years
The Herald Bulletin, Anderson, Ind. · 5m ago
Germany's Merz to press cabinet for faster pro-growth reforms
Reuters · 10m ago
Teen killed at California high school football game; suspect arrested
USA TODAY · 17m ago
Real Madrid snatch late win at Espanyol on Mourinho's return
AFP · 21m ago
Social Security’s $184,500 Wage Cap Is Under Fire. Here’s Exactly Who Would Pay More
24/7 Wall St. · 22m ago
Maresca says Man City must fill Rodri void after Barca switch
AFP · 26m ago
ASEAN Records and ASIA Records Announce Major Expansion as Verified Record Certification Grows Across Asia
TMX Newsfile · 31m ago
Institutional Investors Are Buying Hyperliquid Strategies. Should You?
Motley Fool · 32m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.